Drug Shortage Report for HUMULIN R
| Report ID | 225163 |
| Drug Identification Number | 00586714 |
| Brand name | HUMULIN R |
| Common or Proper name | Insulin, human biosynthetic |
| Company Name | ELI LILLY CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN SEMI SYNTHETIC HUMAN |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | Carton package containing one 10 mL vial |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-04-16 |
| Actual start date | 2024-04-17 |
| Estimated end date | 2024-04-25 |
| Actual end date | 2024-04-23 |
| Shortage status | Resolved |
| Updated date | 2024-04-24 |
| Company comments | Shortage due to manufacturing delay. The estimated end date represents projected availability at the main Lilly warehouse. For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-04-24 | English | Compare |
| v8 | 2024-04-23 | French | Compare |
| v7 | 2024-04-23 | English | Compare |
| v6 | 2024-04-18 | English | Compare |
| v5 | 2024-04-17 | French | Compare |
| v4 | 2024-04-17 | English | Compare |
| v3 | 2024-04-17 | English | Compare |
| v2 | 2024-04-15 | French | Compare |
| v1 | 2024-04-15 | English | Compare |
Showing 1 to 9 of 9